本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Humacyte, Inc.

1.48
-0.0200-1.33%
成交量:204.69萬
成交額:302.82萬
市值:2.34億
市盈率:-3.36
高:1.53
開:1.51
低:1.45
收:1.50
52周最高:6.77
52周最低:1.15
股本:1.58億
流通股本:1.25億
量比:0.78
換手率:1.64%
股息:- -
股息率:- -
每股收益(TTM):-0.4403
每股收益(LYR):-1.2551
淨資產收益率:-249.75%
總資產收益率:-50.18%
市淨率:57.85
市盈率(LYR):-1.18

資料載入中...

2021/11/12

重要事件披露

8-K - Current report
2021/10/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/22

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/21

SEC問詢函

CORRESP [Cover] - Correspondence
2021/09/17

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/09/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/02

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/02

重要事件披露

8-K - Current report
2021/08/30

重要事件披露

8-K - Current report
2021/08/30

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/26

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/08/25

重要事件披露

8-K - Current report
2021/08/17

重要事件披露

8-K - Current report
2021/08/17

企業合併公告

425 - Prospectuses and communications, business combinations
2021/08/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/04

重要事件披露

8-K - Current report
2021/08/04

企業合併公告

425 - Prospectuses and communications, business combinations
2021/08/03

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/02

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/23

SEC問詢函

CORRESP [Cover] - Correspondence